For Vitargus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from For Vitargus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In For Vitargus Today - Breaking & Trending Today

ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues

Published: February 15, 2024

FREMONT, CA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it signed a definitive agreement to license certain of its healthcare-related expertise ("Know-How") to Senior Paradise, Inc. ("SPI"), who will also lease certain of the Company's properties (the "Land") for further development relat

Source: yahoo.com

ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share

Published: February 8, 2024

FREMONT, CA, Feb. 08, 2024 -- via NewMediaWire – ABVC BioPharma, Inc. , a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and...

Source: marketscreener.com

ABVC BioPharma and its Subsidiary Receive $460M From AiBtl

Published: January 3, 2024

FREMONT, CA , Jan. 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) and its subsidiary BioLite, Inc. (

Source: globenewswire.com

ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees

Published: January 3, 2024

FREMONT, CA , Jan. 03, 2024 -- via NewMediaWire – ABVC BioPharma, Inc. and its subsidiary BioLite, Inc. , a clinical-stage biopharmaceutical company developing therapeutic solutions in...

Source: marketscreener.com